Novo A Buys Medtronic PLC, Catalent Inc, Mirum Pharmaceuticals Inc, Sells VANGUARD INDEX FDS, Cable One Inc, Akebia Therapeutics Inc

Author's Avatar
[email protected]
Aug 25, 2020
Article's Main Image
Investment company Novo A (Current Portfolio) buys Medtronic PLC, Catalent Inc, Mirum Pharmaceuticals Inc, Galera Therapeutics Inc, Flexion Therapeutics Inc, sells VANGUARD INDEX FDS, Cable One Inc, Akebia Therapeutics Inc, MyoKardia Inc, Inspire Medical Systems Inc during the 3-months ended 2020Q2, according to the most recent filings of the investment company, Novo A. As of 2020Q2, Novo A owns 34 stocks with a total value of $1.5 billion. These are the details of the buys and sells.

For the details of Novo A's stock buys and sells, go to https://www.gurufocus.com/guru/novo+a/current-portfolio/portfolio

These are the top 5 holdings of Novo A
  1. VANGUARD INDEX FDS (VTI) - 3,070,400 shares, 31.59% of the total portfolio. Shares reduced by 46.97%
  2. Apple Inc (AAPL) - 378,226 shares, 9.07% of the total portfolio. Shares reduced by 7.21%
  3. Inogen Inc (INGN) - 3,549,321 shares, 8.29% of the total portfolio.
  4. Cable One Inc (CABO) - 57,291 shares, 6.68% of the total portfolio. Shares reduced by 23.2%
  5. Brookfield Asset Management Inc (BAM) - 3,070,957 shares, 6.64% of the total portfolio.
New Purchase: Medtronic PLC (MDT)

Novo A initiated holding in Medtronic PLC. The purchase prices were between $84.11 and $103.33, with an estimated average price of $95.86. The stock is now traded at around $102.59. The impact to a portfolio due to this purchase was 5.96%. The holding were 988,136 shares as of .

New Purchase: Catalent Inc (CTLT)

Novo A initiated holding in Catalent Inc. The purchase prices were between $48.02 and $79.04, with an estimated average price of $67.63. The stock is now traded at around $88.35. The impact to a portfolio due to this purchase was 3.97%. The holding were 824,739 shares as of .

New Purchase: Mirum Pharmaceuticals Inc (MIRM)

Novo A initiated holding in Mirum Pharmaceuticals Inc. The purchase prices were between $11.51 and $20.97, with an estimated average price of $16.65. The stock is now traded at around $24.19. The impact to a portfolio due to this purchase was 3.13%. The holding were 2,445,147 shares as of .

New Purchase: Galera Therapeutics Inc (GRTX)

Novo A initiated holding in Galera Therapeutics Inc. The purchase prices were between $7.14 and $14.41, with an estimated average price of $10.61. The stock is now traded at around $7.87. The impact to a portfolio due to this purchase was 1.6%. The holding were 3,409,021 shares as of .

New Purchase: Flexion Therapeutics Inc (FLXN)

Novo A initiated holding in Flexion Therapeutics Inc. The purchase prices were between $6.65 and $13.15, with an estimated average price of $10.3. The stock is now traded at around $11.51. The impact to a portfolio due to this purchase was 1.21%. The holding were 1,403,370 shares as of .

New Purchase: Insmed Inc (INSM)

Novo A initiated holding in Insmed Inc. The purchase prices were between $14.11 and $29.42, with an estimated average price of $23.54. The stock is now traded at around $28.25. The impact to a portfolio due to this purchase was 0.78%. The holding were 430,107 shares as of .

Added: Constellation Pharmaceuticals Inc (CNST)

Novo A added to a holding in Constellation Pharmaceuticals Inc by 159.61%. The purchase prices were between $28.63 and $49.79, with an estimated average price of $35.94. The stock is now traded at around $21.00. The impact to a portfolio due to this purchase was 0.53%. The holding were 437,131 shares as of .

Added: Zogenix Inc (ZGNX)

Novo A added to a holding in Zogenix Inc by 45.98%. The purchase prices were between $22.26 and $32.04, with an estimated average price of $27.52. The stock is now traded at around $22.80. The impact to a portfolio due to this purchase was 0.18%. The holding were 325,814 shares as of .

Added: Intersect ENT Inc (XENT)

Novo A added to a holding in Intersect ENT Inc by 50.71%. The purchase prices were between $9.1 and $14.53, with an estimated average price of $11.63. The stock is now traded at around $19.04. The impact to a portfolio due to this purchase was 0.17%. The holding were 558,515 shares as of .

Added: Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Novo A added to a holding in Biohaven Pharmaceutical Holding Co Ltd by 56.38%. The purchase prices were between $29.01 and $74.23, with an estimated average price of $52.75. The stock is now traded at around $60.58. The impact to a portfolio due to this purchase was 0.15%. The holding were 84,600 shares as of .

Added: Crinetics Pharmaceuticals Inc (CRNX)

Novo A added to a holding in Crinetics Pharmaceuticals Inc by 30.40%. The purchase prices were between $13.04 and $23.23, with an estimated average price of $16.97. The stock is now traded at around $15.53. The impact to a portfolio due to this purchase was 0.06%. The holding were 214,453 shares as of .

Sold Out: MyoKardia Inc (MYOK)

Novo A sold out a holding in MyoKardia Inc. The sale prices were between $44.2 and $121.69, with an estimated average price of $82.77.

Reduced: VANGUARD INDEX FDS (VTI)

Novo A reduced to a holding in VANGUARD INDEX FDS by 46.97%. The sale prices were between $122.96 and $164.1, with an estimated average price of $147.09. The stock is now traded at around $174.45. The impact to a portfolio due to this sale was -24.58%. Novo A still held 3,070,400 shares as of .

Reduced: Cable One Inc (CABO)

Novo A reduced to a holding in Cable One Inc by 23.2%. The sale prices were between $1536.38 and $1960, with an estimated average price of $1786.93. The stock is now traded at around $1829.49. The impact to a portfolio due to this sale was -1.99%. Novo A still held 57,291 shares as of .

Reduced: Akebia Therapeutics Inc (AKBA)

Novo A reduced to a holding in Akebia Therapeutics Inc by 41.42%. The sale prices were between $6.67 and $13.58, with an estimated average price of $10.28. The stock is now traded at around $10.17. The impact to a portfolio due to this sale was -0.75%. Novo A still held 1,987,506 shares as of .

Reduced: Inspire Medical Systems Inc (INSP)

Novo A reduced to a holding in Inspire Medical Systems Inc by 48.56%. The sale prices were between $49.5 and $97.93, with an estimated average price of $76.57. The stock is now traded at around $117.15. The impact to a portfolio due to this sale was -0.32%. Novo A still held 79,536 shares as of .

Reduced: Silk Road Medical Inc (SILK)

Novo A reduced to a holding in Silk Road Medical Inc by 21.83%. The sale prices were between $27.55 and $43.28, with an estimated average price of $38.26. The stock is now traded at around $56.18. The impact to a portfolio due to this sale was -0.09%. Novo A still held 145,428 shares as of .

Reduced: Neuronetics Inc (STIM)

Novo A reduced to a holding in Neuronetics Inc by 43.05%. The sale prices were between $1.41 and $2.61, with an estimated average price of $2.05. The stock is now traded at around $5.33. The impact to a portfolio due to this sale was -0.05%. Novo A still held 514,190 shares as of .



Here is the complete portfolio of Novo A. Also check out:

1. Novo A's Undervalued Stocks
2. Novo A's Top Growth Companies, and
3. Novo A's High Yield stocks
4. Stocks that Novo A keeps buying
Rating:
0 / 5 (0 votes)

Please Login to leave a comment

Please Login to leave a comment